2012Journal of Clinical Pulmonary MedicineRequires access

Clinical observation of tiotropium treatment for COPD patients

Xinmei Zhao

Open publisher page 0 citations

Abstract

Objective To investigate the clinical efficacy of tiotropium inhaler in elderly smokers with stable chronic obstructive pulmonary disease(COPD).Methods 90 elderly smokers with stable COPD were evenly and randomly divided into two groups,and their clinical data were reviewed.The treatment group were given inhaled tiotropium 18 micrograms and albuterol aerosol once a day,and the control group were treated with 0.1 g aminophylline and albuterol aerosol orally every 12 hours.All the patients were followed up for 2 months to observe their improvement.Results In the treatment group,their St George score decreased significantly compared with the control group,and the scores of FEV1/Pred,FEV1,and FEV1/FVC increased obviously(P0.01).However,the control group showed no significant difference(P0.05).Conclusion Inhaled tiotropium and salbutamol aerosol can significantly improve lung function and life quality of elderly smokers with stable COPD.

About this research paper

What this paper is about

Objective To investigate the clinical efficacy of tiotropium inhaler in elderly smokers with stable chronic obstructive pulmonary disease(COPD).Methods 90 elderly smokers with stable COPD were evenly and randomly divided into two groups,and their clinical data were reviewed.The treatment group were given inhaled tiotropium 18 micrograms and albuterol aerosol once a day,and the control group were treated with 0.1 g aminophylline and albuterol aerosol orally every 12 hours.All the patients were followed up for 2 months to observe their improvement.Results In the treatment group,their St George score decreased significantly compared with the control group,and the scores of FEV1/Pred,FEV1,and FEV1/FVC increased obviously(P0.01).However,the control group showed no significant difference(P0.05).Conclusion Inhaled tiotropium and salbutamol aerosol can significantly improve lung function and life quality of elderly smokers with stable COPD.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To investigate the clinical efficacy of tiotropium inhaler in elderly smokers with stable chronic obstructive pulmonary disease(COPD).Methods 90 elderly smokers with stable COPD were evenly and randomly divided into two groups,and their clinical data were reviewed.The treatment group were given inhaled tiotropium 18 micrograms and albuterol aerosol once a day,and the control group were treated with 0.1 g aminophylline and albuterol aerosol orally every 12 hours.All the patients were followed up for 2 months to observe their improvement.Results In the treatment group,their St George score decreased significantly compared with the control group,and the scores of FEV1/Pred,FEV1,and FEV1/FVC increased obviously(P0.01).However,the control group showed no significant difference(P0.05).Conclusion Inhaled tiotropium and salbutamol aerosol can significantly improve lung function and life quality of elderly smokers with stable COPD.

Key concepts: Medicine, Salbutamol, COPD, Aminophylline, Tiotropium bromide, Inhaler, Pulmonary disease, Anesthesia

Related papers

Back to paper searchBrowse research topicsOriginal source
Clinical observation of tiotropium treatment for COPD patients — Research Paper | ScholarLens